The Latest Breaking News from Aflac

Aflac has recently lagged behind the Dow, and analysts have a cautious outlook on the stock’s prospects.

Analysts' ratings for Aflac (NYSE:AFL) over the last quarter vary from bullish to bearish, as provided by 9 analysts.

While Aflac has shown robust market performance and surpassed the broader Nasdaq Composite index over the past year, analysts seem cautious about the stock's potential.

Summary Aflac (AFL) shows strong technical indicators with 100% buy signals, a 47.77% gain in the last year, and a Trend Seeker buy signal. The company operates through Aflac Japan and Aflac U.S., offering various supplemental health and life insurance products. Fundamental factors include a market cap of $61.98 billion,...

When it comes to AI, much is unknown—and therefore risky.

Aflac is a family business and while part of the family may get you in the door, it won't keep you there.

Aflac is expected to report its second-quarter earnings results this month, and Wall Street analysts predict a marginal growth in the company’s bottom line figure.

Aflac has been underperforming the S&P 500 recently, and analysts remain cautious about the stock’s prospects.

Do you want to hear Nick Saban do ASMR? If so, here's your chance.